Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “New York”

Comparison of Axillary Lymph Node Dissection With Axillary Radiation for Patients With Node-Positive Breast Cancer Treated With ChemotherapyActive Not Recruiting
NCT01901094Phase 3Updated Jul 23, 2026
Sponsor: Alliance for Clinical Trials in Oncology
Stage II Breast Cancer · Stage IIIA Breast Cancer
United States, Canada, Puerto Rico
Yale Steroid Enhanced Versus Exparel Nerveblock TKA RCT StudyRecruiting
NCT05279092Phase 2Updated Jul 23, 2026
Sponsor: Yale University
Total Knee Replacement · Knee Arthroplasty
United States
A Phase 1b Study of CLN-049 in Combination With Azacitidine and Venetoclax in AML PatientsNot Yet Recruiting
NCT07722767Phase 1Updated Jul 23, 2026
Sponsor: Cullinan Therapeutics Inc.
AML (Acute Myeloid Leukemia)
United States
A Study With Combinations of Anti-LAG-3 and Anti-PD-1 Antibodies in Adult Participants With Advanced or Metastatic Melanoma (Harmony Head-to-Head)Recruiting
NCT06246916Phase 3Updated Jul 23, 2026
Sponsor: Regeneron Pharmaceuticals
Melanoma
United States, Canada
Selatogrel Outcome Study in Suspected Acute Myocardial InfarctionEnrolling By Invitation
NCT04957719Phase 3Updated Jul 23, 2026
Sponsor: Viatris Innovation GmbH
Acute Myocardial Infarction
United States, Australia, Austria, Belgium, Brazil +40 more
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)Recruiting
NCT07116967Phase 3Updated Jul 23, 2026
Sponsor: Bristol-Myers Squibb
Plaque Psoriasis
United States, Argentina, Australia, Belgium, Brazil +20 more
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)Completed
NCT05899816Phase 3Updated Jul 23, 2026
Sponsor: Amgen
Atopic Dermatitis · Moderate-to-severe Atopic Dermatitis
United States, Canada
A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic DiseasesRecruiting
NCT06806592Phase 3Updated Jul 23, 2026
Sponsor: Boehringer Ingelheim
Interstitial Lung Diseases · Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
United States, Australia, Austria, China, France +11 more
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple SclerosisActive Not Recruiting
NCT03523858Phase 3Updated Jul 23, 2026
Sponsor: Hoffmann-La Roche
Progressive Multiple Sclerosis (PMS)
United States, Bosnia and Herzegovina, Brazil, Canada, Colombia +19 more
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed OsteosarcomaRecruiting
NCT05691478Phase 2, Phase 3Updated Jul 23, 2026
Sponsor: National Cancer Institute (NCI)
High Grade Osteosarcoma · Localized Osteosarcoma · Metastatic Osteosarcoma · Secondary Osteosarcoma
United States, Australia, Canada, New Zealand
Titrated Ambulatory Oxygen in Fibrotic ILD and COPD With Isolated Exertional HypoxemiaRecruiting
NCT07512687NAUpdated Jul 23, 2026
Sponsor: State University of New York at Buffalo
Interstitial Lung Disease · Chronic Obstructive Pulmonary Disease · Hypoxemia
United States
Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care CoordinationCompleted
NCT05820295NAUpdated Jul 23, 2026
Sponsor: Weill Medical College of Cornell University
Cardiovascular Diseases · Myocardial Infarction · Atrial Fibrillation · Diabetes Mellitus
United States
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)Recruiting
NCT07220083Phase 3Updated Jul 23, 2026
Sponsor: Boehringer Ingelheim
Focal Segmental Glomerulosclerosis
United States, Argentina, Australia, Belgium, Brazil +35 more
A Study of Tucatinib vs. Placebo in Combination With Ado-trastuzumab Emtansine (T-DM1) for Patients With Advanced or Metastatic HER2+ Breast CancerActive Not Recruiting
NCT03975647Phase 3Updated Jul 23, 2026
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
HER2-positive Breast Cancer
United States, Australia, Austria, Belgium, Canada +15 more
Yale Steroid Enhanced Versus Exparel Nerveblock TKA Part 2Recruiting
NCT05736549Phase 2Updated Jul 23, 2026
Sponsor: Yale University
Total Knee Replacement · Knee Arthroplasty
United States
DBC-664 in Adult Patients With Solid TumorsRecruiting
NCT07705035Phase 1Updated Jul 23, 2026
Sponsor: Duboce Biopharmaceuticals, Inc.
Malignant Germ Cell Tumor · Lung Adenocarcinoma · Gastric/Esophageal/Gastroesophageal Junction (GEJ) Adenocarcinoma · Urothelial Carcinoma
United States
A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic AtrophyRecruiting
NCT06779773N/AUpdated Jul 23, 2026
Sponsor: Astellas Pharma Global Development, Inc.
Geographic Atrophy · Macular Degeneration
United States
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)Recruiting
NCT06220201Phase 1Updated Jul 23, 2026
Sponsor: Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Multiple Sclerosis · Myasthenia Gravis
United States, Belgium, France, Germany, Spain +1 more
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral RegurgitationActive Not Recruiting
NCT03433274NAUpdated Jul 23, 2026
Sponsor: Abbott Medical Devices
Mitral Regurgitation · Mitral Insufficiency · Mitral Valve Insufficiency · Cardiovascular Diseases
United States, Canada
Testing Early Treatment for Patients With High-Risk Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL), EVOLVE CLL/SLL StudyRecruiting
NCT04269902Phase 3Updated Jul 23, 2026
Sponsor: National Cancer Institute (NCI)
Chronic Lymphocytic Leukemia · Small Lymphocytic Lymphoma
United States, Canada
Trial of Therapeutic Cancer Vaccine OSE2101 in Patients With Non-Small Cell Lung Cancer and Secondary Resistance to Immune Checkpoint InhibitorRecruiting
NCT06472245Phase 3Updated Jul 23, 2026
Sponsor: OSE Immunotherapeutics
Patients With Non-Small Cell Lung Cancer
United States, Belgium, Canada, France, Germany +9 more
IM ABLE 2: Injuries Managed With Advanced Bracing for Lower ExtremitiesRecruiting
NCT07721792NAUpdated Jul 23, 2026
Sponsor: University of South Florida
Lower Limb Injury · Ankle Foot Orthosis (AFO) · Lower Limb Trauma
United States
Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®Terminated
NCT05900050Phase 2Updated Jul 23, 2026
Sponsor: Genfit
Acute-On-Chronic Liver Failure · Ascites
United States, Belgium, France, Germany, Hungary +2 more
CardiolRx in Recurrent Pericarditis (MAVERIC Phase-3)Recruiting
NCT06708299Phase 3Updated Jul 23, 2026
Sponsor: Cardiol Therapeutics Inc.
Recurrent Pericarditis
United States, Canada, Greece, Italy
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening TrialRecruiting
NCT05564377Phase 2Updated Jul 23, 2026
Sponsor: National Cancer Institute (NCI)
Advanced Malignant Solid Neoplasm · Anatomic Stage III Breast Cancer AJCC v8 · Anatomic Stage IV Breast Cancer AJCC v8 · Locally Advanced Malignant Solid Neoplasm
United States, Puerto Rico

Previous page Next page